Screening for latent tuberculosis in migrants—status quo and future challenges
International Journal of Infectious Diseases · 2024-04 · 141 · 107002
DOI: 10.1016/j.ijid.2024.107002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Infectious Diseases, 2024-04. Verfasst von Eskild Petersen und 9 weiteren Autor:innen. Beteiligte Einrichtung: PandemiX Center of Excellence, Roskilde University, Roskilde, Denmark; European Society for Clinical Microbiology and Infectious Diseases Task Force …. Hauptthemen laut MEDLINE: Latent Tuberculosis, Transients and Migrants, Tuberculosis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
OBJECTIVES: To review the evidence that migrants from tuberculosis (TB) high-incidence countries migrating to TB low-incidence countries significantly contribute to active TB cases in the counties of destination, primarily through reactivation of latent TB. METHODS: This is a narrative review. The different screening programs in the countries of destination are reviewed either based on screening and preventive treatment of latent TB pre or more commonly - post arrival. RESULTS: Screening can be performed using interferon-gamma release assays (IGRA) or tuberculin skin tests (TST). Preventive treatment of latent TB is using either monotherapy with isoniazid, or in combination with rifampicin or rifapentine. We discuss the ethical issues of preventive treatment in asymptomatic individuals and how these are addressed in different screening programs. CONCLUSION: Screening migrants from TB high endemic countries to TB low endemic countries is beneficial. There is a lack of standardization and agreement on screening protocols, follow up and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- PandemiX Center of Excellence, Roskilde University, Roskilde, Denmark; European Society for Clinical Microbiology and Infectious Diseases Task Force for Emerging Infections, Basel, Switzerland; International Society for…
- Directorate General for Disease Surveillance and Control, Ministry of Health, Muscat, Oman. Electronic address: salabri@gmail.com.
- Central Public Health Laboratory, Ministry of Health, Muscat, Oman.
- Research and Innovation Center, King Saud Medical City, Ministry of Health & College of Medicine, Al Faisal University, Riyadh, Saudi Arabia; Hubert Department of Global Health, Rollins School of Public Health, Emory Un…
- Department of Global Public Health, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
- Fondation Congolaise pour la Recherche Médicale, Brazzaville, People's Republic of Congo; Institute for Tropical Medicine, University of Tübingen, Tübingen, Germany.
Zitieren
APA
Petersen, E., Al-Abri, S., Al-Jardani, A., Memish, Z. A., Aklillu, E., Ntoumi, F., Mwaba, P., Wejse, C., Zumla, A., & Al-Yaquobi, F. (2024). Screening for latent tuberculosis in migrants—status quo and future challenges. International Journal of Infectious Diseases, 141, 107002. https://doi.org/10.1016/j.ijid.2024.107002
Vancouver
Petersen E, Al-Abri S, Al-Jardani A, Memish ZA, Aklillu E, Ntoumi F, et al. Screening for latent tuberculosis in migrants—status quo and future challenges. International Journal of Infectious Diseases. 2024;141:107002. doi:10.1016/j.ijid.2024.107002
BibTeX
@article{Petersen2024,
author = {Petersen, Eskild and Al-Abri, Seif and Al-Jardani, Amina and Memish, Ziad A and Aklillu, Eleni and Ntoumi, Francine and Mwaba, Peter and Wejse, Christian and Zumla, Alimuddin and Al-Yaquobi, Fatma},
title = {Screening for latent tuberculosis in migrants—status quo and future challenges},
journal = {International Journal of Infectious Diseases},
year = {2024},
volume = {141},
pages = {107002},
doi = {10.1016/j.ijid.2024.107002}
}
EUVIMED